Glycosuria contributes directly to improved glycemic control, while increased distal sodium delivery restores normal tubuloglomerular feedback, thereby lowering intraglomerular pressure, which is a key mechanism in slowing DKD progression [25,27]
Losing muscle along with fat reduces metabolic rate and creates the conditions for weight regain
By acting on all three of these receptors, Retatrutide offers a multi-pronged approach to weight loss and metabolic control, making it a promising treatment option for individuals struggling with obesity or metabolic conditions such as type 2 diabetes
The SURPASS-CVOT trial (NCT04255433) will assess the cardiovascular safety of tirzepatide compared to dulaglutide in people with T2D and established atherosclerotic disease [111]
March 2018
Recognising Allergic Reactions to GLP-1 Agonists Common Symptoms and Warning Signs to Watch For What to Do If You Experience an Allergic Reaction Risk Factors and Who May Be More Susceptible Alternative Treatments and Next Steps Scientific References Frequently Asked Questions What Are GLP-1 Agonists and How Do They Work